id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-253746-15w4gquq	Goldman, Michel	Reflections on the Collaborative Fight Against COVID-19	2020-09-17		.txt	text/plain	1633	75	41	As therapeutic interventions in the early phase of the disease are attracting more and more interest, we argue that now is the time to involve patients' organizations in the design of clinical protocols in order to define the most relevant end-points and assess the risk-benefit balance of new therapies. In this editorial perspective, we argue that patients' voice will be essential to ensure uptake in the wider public of new therapies and vaccines resulting from these initiatives. Therefore, it is essential that trials are designed to include sufficient numbers of patients within the period of time during which the pandemic is expected to be active. Furthermore, patient reported outcomes are essential to assess the impact of therapeutic interventions on the long-term consequences of COVID-19 (13) . It is therefore important that patient organizations are involved early on in the design of clinical trials.	./cache/cord-253746-15w4gquq.txt	./txt/cord-253746-15w4gquq.txt